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Background: The comprehensive analysis of human kidney glomerulus we previously performed using highly
purified glomeruli, provided a dataset of 6,686 unique proteins representing 2,966 distinct genes. This dataset,
however, contained considerable redundancy resulting from identification criteria under which all the proteins
matched with the same set of peptides and its subset were reported as identified proteins. In this study we
reanalyzed the raw data using the Mascot search engine and highly stringent criteria in order to select proteins
with the highest scores matching peptides with scores exceeding the “Identity Threshold” and one or more unique
peptides. This enabled us to exclude proteins with lower scores which only matched the same set of peptides or its
subset. This approach provided a high-confidence, non-redundant dataset of identified proteins for extensive
profiling, annotation, and comparison with other proteome datasets that can provide biologically relevant
knowledge of glomerulus proteome.
Results: Protein identification using the Mascot search engine under highly stringent, computational strategy
generated a non-redundant dataset of 1,817 proteins representing 1,478 genes. These proteins were represented by
2-D protein array specifying observed molecular weight and isoelectric point range of identified proteins to
demonstrate differences in the observed and calculated physicochemical properties. Characteristics of glomerulus
proteome could be illustrated by GO analysis and protein classification. The depth of proteomic analysis was well
documented via comparison of the dynamic range of identified proteins with other proteomic analyses of human
glomerulus, as well as a high coverage of biologically important pathways. Comparison of glomerulus proteome
with human plasma and urine proteomes, provided by comprehensive analysis, suggested the extent and
characteristics of proteins contaminated from plasma and excreted into urine, respectively. Among the latter
proteins, several were demonstrated to be highly or specifically localized in the glomerulus by cross-reference
analysis with the Human Protein Atlas database, and could be biomarker candidates for glomerular injury.
Furthermore, comparison of ortholog proteins identified in human and mouse glomeruli suggest some biologically
significant differences in glomerulus proteomes between the two species.
Conclusions: A high-confidence, non-redundant dataset of proteins created by comprehensive proteomic analysis
could provide a more extensive understanding of human glomerulus proteome and could be useful as a resource
for the discovery of biomarkers and disease-relevant proteins.
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The glomerulus is the site of plasma filtration and produc-
tion of primary urine in the kidney. Not only does the
glomerulus play a pivotal role in the ultrafiltration of
plasma into urine but it is also the locus of kidney diseases
which often progress to chronic renal failure. The diagno-
sis and treatment of glomerular diseases are now based on
clinical manifestations, urinary protein excretion level,
and the renal pathology of needle biopsy specimens. The
cellular and matrix architecture of the glomeruli of biopsy
specimens have been mapped in detail, providing a basis
for diagnosis, classification, and clinical treatment deci-
sions. In contrast to the detailed information about
morphological changes in the glomerulus, the molecular
composition of the glomerulus and how it changes with
the progress of the diseases are still obscure. Identification
and characterization of biomarkers and proteins relevant
to the onset and progress of diseases, therefore, are of high
priority, as they would allow better disease classification,
detection, and prognosis. Proteomic analysis of the glom-
erulus could be the most straightforward approach toward
discovery of disease-related proteins [1], while most efforts
of proteomic analyses have been focused on urine [2,3].
We have previously analyzed glomeruli purified from
kidney cortex with no apparent pathological manifesta-
tions in order to compile an in-depth profile of the normal
human glomerulus proteome as a resource for clinical
research [4]. The large-scale shotgun proteomic analysis
provided a dataset of 6,686 identified proteins representing
2,966 distinct genes. The dataset, however, contained con-
siderable redundancy: proteins produced by alternative
splicing of primary mRNAs from the same gene and pro-
teins produced from gene families containing highly con-
servative regions of nucleotide or amino acid sequences
are included in the dataset. These proteins were generally
identified with lower score and arose from both bioinfor-
matics and biological redundancy because all the proteins
matched with the same set of peptides or its subsets were
reported as identified proteins. Redundancy is unavoidable
in peptide-based protein identification in mass spectrom-
etry, i.e., bottom-up or shotgun analysis. Although we
could not exclude the actual presence of these proteins,
the redundant dataset obviously contained many ambigu-
ously identified proteins as explained above, and could
considerably affect profiling and annotation of proteome
under analysis.
In the present study, we reanalyzed raw data obtained in
our previous, large-scale proteomic analysis to generate a
high-confidence, non-redundant dataset of identified pro-
teins by using the Mascot search engine and highly strin-
gent, computational strategy for extensive profiling and
annotation of the normal human glomerulus proteome
[5]. The identified proteins were represented by 2-D pro-
tein array specifying actual molecular weight (Mw) andisoelectric point (pI) range to demonstrate differences in
the observed and calculated physicochemical properties,
often lost in shotgun analysis. Characteristics of the glom-
erulus proteome were illustrated by Gene Ontology (GO)
analysis and protein classification with the aid of bioinfor-
matics tools. The depth of proteomic analysis was well
documented by comparing the dynamic range of identi-
fied proteins with other proteomic analyses targeting the
glomerulus. Comparison of the glomerulus proteome with
comprehensive analyses of the human plasma and human
urine proteomes suggested the extent and characteristics
of proteins contaminated from plasma and excreted into
urine, respectively. Furthermore, a comparison of ortholog
proteins identified in human and mouse glomerulus sug-
gested some biologically significant differences between
the two species. The extensive profiling and annotation of
the human glomerulus proteome were first conducted in
this study and could be a useful resource for the discovery
of biomarkers and disease-relevant proteins.Results and discussion
Protein identification
In our previous study [4], glomeruli from the kidney
cortex of a 68-year-old male patient who had undergone
a nephrectomy due to ureter carcinoma were purified to
apparent homogeneity by the sieving method. The cor-
tex was histologically normal on the basis of light
microscopic observations of PAS- and PAM-stained tis-
sue and no significant deposition of immunoglobulins
(IgA, IgG, and IgM) or complement C3 was observed by
immunofluorescence microscopy. In the previous study,
protein extract from the glomerular preparation was
fractionated by two procedures; 1-D SDS-PAGE and 2-D
pre-fractionation using solution phase isoelectric focusing
(IEF) followed by 1-D-SDS-PAGE. All SDS-PAGE lanes
were cut into 15 slices corresponding to a total of 90 slices
or fractions, processed by in-gel trypsin digestion, and
analyzed by a nanoflow-ESI-ion trap mass spectrometer.
Peptides recovered from each gel slice were analyzed in
duplicate by two consecutive LC-MS/MS runs followed by
two consecutive blank LC-MS/MS runs. The four raw
data files generated were merged and identified using the
Spectrum Mill search engine (for details, see Additional
file 1). In this study, the four raw data files for each of the
fractions were converted into Mascot generic files via a
Data Analysis software (Agilent) and used for protein
identification using the Mascot search engine against the
IPI_human protein sequence database (ver. 3.70) to create
a dataset of high-confidence, non-redundant identified
proteins (see Methods section). In addition, the same raw
data files were analyzed by Spectrum Mill using the same
version of the IPI_human protein sequence database for
convenience of comparison.
Table 1 Summary of proteins identified by Mascot and
Spectrum Mill
A Proteins identified by Spectrum Mill














Fr. 1 (pH 3–4.6) 1189 708 1897
Fr. 2 (pH 4.6-5.4) 1753 827 2580
Fr. 3 (pH 5.4-6.2) 1423 886 2309
Fr. 4 (pH6.2-7.0) 2228 909 3137
Fr. 5 (pH 7.0-10.0) 1699 841 2540













Fr. 1 (pH 3–4.6) 268 123 391
Fr. 2 (pH 4.6-5.4) 393 178 571
Fr. 3 (pH 5.4-6.2) 370 139 509
Fr. 4 (pH6.2-7.0) 562 171 733
Fr. 5 (pH 7.0-10.0) 416 147 563







aThe number of identified proteins with two or more peptide matches
counted by using the non-redundant dataset of identified proteins. bThe
number of identified proteins with one peptide match counted by using non-
redundant dataset of identified proteins. cThe sum of the number of identified
proteins with high confidence and low confidence as defined above.
dGlomerular proteins were directly separated into 15 fractions by one-
dimensional (1-D) SDS-PAGE. eGlomerular proteins were separated into 5
fractions with different pI ranges by solution-phase IEF in the first dimension
and each fraction was further separated into 15 fractions by 1-D SDS-PAGE in
the second dimension. fThe sum of the numbers of proteins identified in each
fraction of 2-D pre-fractionation with high confidence or low-confidence as
defined above. gThe sum of identified proteins counted by using the non-
redundant dataset created by merging all the identified proteins in fractions
of 1-D and 2-D pre-fractionation. hTotal distinct proteins included proteins
derived from the same genes. In order to identify total distinct genes, the
same gene symbols dispersed in the dataset were processed in an Excel work
sheet to merge into one gene symbol by using the “Remove Duplicate”
command.
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Mascot are summarized in Table 1 (for details of protein
IDs by Mascot, see Additional file 2). There was a signifi-
cant difference in the number of proteins identified by
Spectrum Mill and Mascot, which could be explained by
the presence of considerable redundancy in proteins in
the Spectrum Mill dataset, as discussed in “Background”
section and Additional file 3.
The protein identification was conducted with pro-
teins in respective fractions among the 90 fractions
obtained by 1-D and 2-D pre-fractionation. Since the
respective fractions could be defined by Mw and pI
range, proteins identified in these fractions could be
provided with the two intrinsic physicochemical proper-
ties. We, therefore, compiled the proteins identified in
this study into a 1-D protein array consisting of 15 sec-
tions defined by Mw range and to a 2-D protein array
consisting of 75 sections defined by Mw and pI range
(Figure 1, see Additional file 4 and Additional file 5 for
details of protein IDs).
Comparison of the 2-D protein array with the distri-
bution of calculated pI and Mw of the identified pro-
teins clearly indicated significant differences between
the observed and calculated pI and Mw for the identi-
fied proteins. The difference may be illustrated by plot-
ting the calculated Mws of identified proteins in each
gel slice of SDS-PAGE gel (Figure 2) and calculated pIs
in each fraction of solution phase IEF (Figure 3).
We confirmed successful fractionation with minimal
cross-contamination of the solution phase IEF in the
first dimension of 2-D pre-fractionation of glomerular
proteins [4]. Nevertheless, the difference between ob-
served and calculated pI and Mw was obvious. These
observations could possibly be explained by aggregation,
degradation or posttranslational modifications (i.e. gly-
cosylation and phosphorylation) of actual proteins in
tissue lysate. The solution phase IEF in the first dimen-
sion of 2-D pre-fractionation of proteins resulted in
extensive condensing of proteins in their pI ranges,
which might have contributed to aggregation and/or
degradation. The prolonged time required for 2-D pre-
fractionation of proteins could also contribute to aggre-
gation as well as degradation of proteins. This result
may impose the need for careful consideration on
peptide-based targeted proteomics for qualitative and
quantitative analysis if protein fractionation is uti-
lized to concentrate target proteins prior to targeted
proteomic analysis.
Figure 4 depicts locations in fractions produced by
2-D pre-fractionation of glomerular proteins of the four
key molecules related to the slit diaphragm, a critical
filtration barrier of plasma proteins in the glomerulus,
along with their calculated (theoretical) Mws and pIs.
Nephrin, Neph-1 and Fyn were identified mostly in their
1-D 2-D
Slice Fraction 1 Fraction 2 Fraction 3 Fraction 4 Fraction 5
1 40 59 61 40 28 37
2 48 55 54 40 31 36
3 65 60 60 49 35 39
4 77 62 69 60 45 48
5 74 71 59 57 57 60
6 94 65 107 67 52 56
7 90 24 68 35 93 66
8 113 70 49 77 99 74
9 67 73 75 32 132 78
10 120 53 61 53 139 80
11 115 71 90 96 111 77
12 122 62 85 79 121 99
13 113 73 83 84 101 105
14 74 62 81 65 113 80
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Figure 1 The number of identified proteins in fractions of 1-D and 2-D pre-fractionation of glomerular proteins. The number of proteins
identified in each of the 90 fractions separated by 1-D (SDS-PAGE) and 2-D pre-fractionation (solution phase isoelectric focusing followed by
SDS-PAGE) are shown in 1-D and 2-D protein array format in which each cell or fraction is defined with Mw and pI range. The workflow for the
protein identification strategy is depicted in Additional file 1, and details of identified proteins are shown in Additional file 4 and Additional file 5.
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be aggregated or associated strongly with large molecular
weight proteins and appeared in acidic fractions far from
its calculated Mw and pI.
Characterization of glomerulus proteome using
bioinformatics tools
All the identified proteins included in the non-redundant,
high-confidence dataset consisting of 1,817 unique pro-
teins representing 1,478 unique genes were subjected to
bioinformatics analysis based on the structured vocabulary
of Gene Ontology (GO) using a PANTHER analytical
tool (ver. 7.0) [6,7]. Subcellular distribution as esti-
mated by analysis with GO Cellular Component vo-
cabulary indicated the highest number of hits to the
actin cytoskeleton and a considerably higher number
of hits to the intermediate filament cytoskeleton and
the extracellular region (a term defining proteins
present in the external protective or encapsulating
structure outside the plasma membrane including the
extracellular matrix) (Additional file 6: Figure S1A).
The classification of proteins based on GO Molecular
Function vocabulary (Additional file 6: Figure S1B) and
Biological Process vocabulary (Additional file 6: Figure
S2A) yielded the successful identification of unbiased,widely diverse proteins. Enrichment analysis based on
GO Biological Process vocabulary using Cytoscape
(version 2.82) with the BinGO plug-in (version 2.42)
[8] further illustrated biological processes in which
glomerular proteins are significantly enriched com-
pared to products of whole human genes (p < 0.001,
hypergeometric test followed by multiple testing cor-
rection using Benjamin and Hochberg false discovery
rate correction) (Additional file 6: Figure S2B).
Under-representation or depletion analysis based on
GO Biological Process vocabulary using Cytoscape, as
described above, indicated significant depletion of pro-
teins involved in “sensory perception”, “regulation of
small GTPase mediated signal transduction”, especially
in “regulation of Ras protein signal transduction”, and,
most notably, in “regulation of transcription” including
“regulation of transcription from RNA polymerase II
promoter” (Additional file 7).
PANTHER Protein Class analysis is based on PANTHER
Molecular Function ontology, which includes commonly
used classes of protein functions, many of which are not
covered by GO Molecular Function. PANTHER Protein
Class analysis again showed that the highest number of
proteins was classified as cytoskeletal proteins (Additional
file 6: Figure S3).
Figure 2 Distribution of calculated molecular weight of proteins identified in each fraction separated by SDS-PAGE in 2-D
prefractionation of glomerular proteins. Fractions obtained by solution phase isoelectric focusing (fractions 1 to 5) were separated on a 10%
SDS-PAGE gel (2-D prefractionation of glomerular proteins), and stained with Coomassie Brilliant blue. Each of the five lanes was cut into 15
slices, and in-gel digested with trypsin for LC-MS/MS analysis. Proteins identified in each of the 5 slices at the same position across the 5 lanes
(S1 to S15) were integrated and used to construct a histogram based on calculated (theoretical) Mw as indicated. The red arrow indicates the
observed molecular mass range.
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kidney glomerulus
We assessed the depth of our comprehensive analysis
of the human kidney proteome by comparison with
two high-confidence, non-redundant datasets of prote-
omic analysis of human and mouse glomeruli. The
former was the result of analysis of human glomerulus
laser-microdissected from frozen sections of biopsy
specimens using conventional HPLC in combination
with an LTQ-Orbitrap mass spectrometer [9], provid-
ing identification of more than 400 proteins from 50
glomerular sections. The latter was the result of ana-
lysis of laser-microdissected mouse kidney glomerulus
by employing a newly developed nanoflow HPLC on a
long, smaller internal diameter column coupled with
an LC-MS interface, termed “Replay”. This system
allows the direct reanalysis of the injected sample with-
out losing signal intensity [10], providing identification
of more than 2,400 proteins from 50 glomerular
sections by an LTQ-Orbitrap mass spectrometer.Figure 5 shows a comparison of the dynamic ranges of
identified proteins achieved by the three analyses to which
the four key proteins related to the slit diaphragm of
glomerulus were mapped. As expected, the dynamic range
of the proteomic analysis of 50 human glomerular sections
was the lowest while those of the proteomic analyses of
human glomerulus proteome and the state-of-art analysis
of laser-microdissected mouse glomerulus proteome were
1.5, and 3 times higher than the analysis of the 50 human
glomerular sections, respectively. It was noted that the
number of identified proteins in the middle range of con-
centrations were much higher in the latter two analyses
contributing to the difference in the number of identified
proteins. This difference could be attributable to the ex-
tensive fractionation of glomerular proteins in the present
analysis and to the high-resolution HPLC in combination
with the Replay approach of the LC-MS interface
employed in the analysis of the 50 mouse glomerular sec-
tions. The four slit diaphragm-related proteins, namely
nephrin, podocin, Neph1 and Fyn, were identified in the
Figure 4 Location of identification of four key molecules related to the slit diaphragm in fractions of 2-D prefractionation of
glomerular proteins. Distribution of nephrin, podocin, Neph1, and Fyn, known to be key components of the slit diaphragm of podocytes, is shown in
the 2-D protein array. Sections, in which these proteins were identified, are highlighted with red colour gradation corresponding to the number of
peptides matched to respective proteins. The calculated (theoretical) Mw and pI are indicated below the 2-D protein array for each of the four proteins.
Figure 3 Distribution of calculated isoelectric point of identified proteins among fractions of solution phase isoelectric focusing.
Proteins fractionated by solution phase IEF (fractions 1 to 5) were separated on a 10% SDS-PAGE gel (2-D prefractionation of glomerular proteins), and
stained with Coomassie Brilliant blue. Each of the five lanes was cut into 15 slices, and in-gel digested with trypsin for LC-MS/MS analysis. All the proteins
identified in each of the 5 IEF fractions (F1 to F5) were integrated, and used to construct a histogram based on calculated (theoretical) pI as indicated. The
red arrow indicates the observed pI range.
Cui et al. Proteome Science 2013, 11:13 Page 6 of 12
http://www.proteomesci.com/content/11/1/13
Figure 5 Comparison of dynamic range of proteomic analyses.
Dynamic ranges of identified proteins achieved by the present study
are shown in comparison with those of two proteomic analyses of
human (Human glomerulus (LMD)) and mouse glomerulus. The
former is the result of analysis of 50 human glomerular sections
prepared by laser-microdissection from frozen sections of each of 3
different biopsy specimens using conventional HPLC in combination
with an LTQ-Orbitrap mass spectrometer [9]. Four replicate runs
were conducted for each of the 3 samples and all the identified
proteins were integrated to create a high-confidence, non-
redundant dataset of identified proteins (604) under the criteria
adopted in this study. The high-confidence, non-redundant dataset
of mouse glomerulus proteome was taken from Waanders et al. [10]
who analyzed the proteins of 50 glomerular sections laser-
microdissected from mouse kidneys using a newly developed
nanoflow HPLC. The nanoflow HPLC’s long, smaller internal diameter
column coupled with the LC-MS interface “Replay” allowed the
reanalysis of the injected sample with high sensitivity, and with an
LTQ-Orbitrap mass spectrometer, provided 2,670 proteins.
Normalized spectral abundance factor (NSAF), a relative protein
abundance index, was calculated according to Paoletti et al. [12].
NSAF is based on the number of peptide matches (spectral counts)
divided by protein mass or protein length which roughly correlates
with protein concentration in a protein mixture (spectral abundance
factor, SAF). To accurately account for run to run variation, individual
SAF was normalized by dividing the SAF of a respective protein by
the sum of SAFs for all identified proteins to give an NSAF
representing relative protein abundance. NSAFs for the four key
proteins comprising the slit diaphragm of glomerulus (nephrin,
podocin, Neph1 and Fyn) are mapped on each of the
abundance curves.
Figure 6 Comparison of glomerulus proteome with plasma
proteome. Contamination of plasma proteins in the glomerulus
proteome was roughly estimated by comparison with a high-
confidence, non-redundant dataset of normal human plasma
proteome [13]. Among the 401 overlapping proteins between the
two proteomes, representing 22.1% of the glomerulus proteome, 40
proteins, annotated as “extracellular space” by GO Cellular
Component vocabulary, were selected as plasma proteins to exclude
low-abundance, tissue-leakage proteins including intrinsic
glomerular proteins. See the text for more details.
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Fyn, a non-receptor tyrosine kinase, was lost in the ana-
lysis of the 50 human glomerulus sections. DAVID KEGG
pathway analysis [11] predicted an over-representation of
the actin cytoskeleton regulatory pathway (Additional file 8).Comparison of glomerulus proteome with human plasma
proteome
Inclusion of blood-derived proteins in glomerulus prote-
ome was unavoidable since the removal of blood from
kidney tissue by perfusion with a physiological solution
was impossible before the sampling of kidney cortices for
the purification of glomeruli. We therefore roughly esti-
mated the extent of blood contamination by comparing
glomerulus proteome with normal human plasma prote-
ome consisting of 3,020 non-redundant proteins with two
or more peptide matches [13]. Figure 6 depicts the overlap
between our glomerulus proteome and the normal human
plasma proteome indicating that 401 proteins (22.1% of
glomerulus proteome) were commonly identified in both
proteomes. Since the plasma proteome contained low-
abundant tissue leakage proteins including intrinsic kidney
proteins in addition to abundant classical plasma proteins
[14], we estimated the extent of contamination of classical
plasma proteins in the glomerulus proteome by specifying
proteins annotated with “extracellular space” by GO
Cellular Component vocabulary, “Extracellular space” is
defined as the part of a multicellular organism outside the
cell proper, usually taken to be outside the plasma mem-
brane, and occupied by fluid, excluding proteins located in
the outmost protective or encapsulating structure of a cell.
Among the 401 overlapping proteins, 80 were annotated
Figure 7 Comparison of glomerular proteome with urine proteome. Excretion of glomerular proteins into urine was roughly estimated by
comparison with a high-confidence, non-redundant dataset of normal human urine proteome [15]. In Panel A, the two proteome datasets were
directly compared to estimate overlapped proteins. Among the 445 overlapped proteins representing 24.5% of the glomerular proteome, 95
proteins annotated as “extracellular space” (presumably representing plasma proteins) by GO Cellular Component vocabulary were found. In
Panel B, the two proteome datasets from which “extracellular space” proteins were depleted were compared to estimate glomerular proteins
excreted into urine by removing plasma proteins which were identified in both proteomes.
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Additional file 9 for the top 30 plasma proteins identified
in glomerulus proteome).Comparison of glomerulus proteome with human urine
proteome
Most efforts made in proteomics toward the discovery
of biomarkers and disease-related proteins of acute kid-
ney injuries (AKI) and chronic kidney diseases (CKD)
have been focused on urinary samples because of non-
invasiveness collection [2,3], and ease of follow-up study.
We compared glomerular proteome with normal hu-
man urine proteome consisting of non-redundant high-
confidence 1,548 proteins [15]. Figure 7A depicts the
overlap between our glomerulus proteome and the normal
human urine proteome, indicating that 445 proteins
(24.5% of the glomerular proteome) were commonly iden-
tified in both proteomes. Figure 7B shows a comparison of
the two proteomes deprived of “extracellular space” pro-
teins to remove plasma proteins as discussed above, which
were present in both proteomes, again indicating that
23.4% of glomerular proteins were commonly identified in
both proteomes. Among the 392 proteins, we looked for
proteins originated from the glomerulus by searching in
the Human Protein Atlas, an antibody-based, comprehen-
sive proteome database for the systemic exploration of hu-
man proteome by profiling cells and tissues using
immunohistochemistry [16]. Additional file 10 provides
59 proteins which were shown to be expressed in the
glomerulus in the Human Protein Atlas. These proteins
may include possible urinary biomarkers for glomerularinjury in AKI and CKD, although confirmation by clinical
studies is necessary.
Comparison of glomerulus proteome with mouse
glomerulus proteome
Waanders et al. reported a comprehensive proteomic
analysis of mouse glomerulus prepared by laser micro-
dissection from frozen tissue sections [10], providing
identification of more than 2,400 proteins as described
above. In the analysis of mouse glomerulus [10], MS/
MS data were processed by MaxQuant and searched
against the mouse IPI database (ver. 3.37), using Mascot
(version 2.1). Parameter settings for their search were
similar to those of our study, except that peptide and
fragment mass tolerance were set at 7 ppm and 0.5 Da,
respectively, and proteins were considered identified
when at least two peptides were identified, and at least
one of which was uniquely assignable to the respective
sequence to exclude redundant protein hits. The false
discovery rate (FDR) at the peptide level was set to 1%.
The dataset of mouse glomerulus proteome, therefore,
was highly confident, non-redundant, and almost compar-
able to our study. In order to compare both proteomes
and gain insight into differences between the two, first, we
constructed an ortholog table of human and mouse genes
and converted the mouse gene symbols to corresponding
human ortholog gene symbols. The ortholog table of hu-
man and mouse genes was constructed based on an “Evola
ortholog list” (version 7.5) in the Human-Invitational
Database (H-Inv DB) [17]. To construct an Evola ortholog
list in the H-Inv DB, a list of human genes was created
via the mapping of all human full-length transcripts to
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alignment search engines including BLAT, BLAST and
est2genome. For other species, gene loci were similarly
predicted through the mapping of all transcripts from
DDBJ, RefSeq and Ensemble nucleotide sequence data-
bases to genomic sequences. The Evola ortholog list was
then generated if exons overlapped between species in
genomic alignment for the longest for both the human
side and the other species’ side: the pairs were detected
as ortholog by computational analysis if they could be
aligned with a length of 50% or more of the human
amino acid sequence. Using this approach, a pair of
ortholog genes in the two species under comparison,
which were generated from an ancestor gene by specifi-
cation, was selected.
Among 1,478 genes identified in the human glomerulus,
1,320 genes were found in the human-mouse ortholog
table while 2,300 genes identified in the mouse glomerulus
were found in the table. Figure 8 shows a comparison of
ortholog genes identified in both proteomes. The relatively
high overlap between the two proteomes (74.0% of
genes identified in the human glomerulus proteome)
was observed, demonstrating that most of the human
genes expressed in glomerulus were also expressed in
the mouse glomerulus. The high number of genes
uniquely identified in the mouse glomerulus could be
attributed to the much higher number of proteins iden-
tified in the mouse glomerulus. The relatively high
number of genes (343) uniquely identified in the human
glomerulus could be explained by the presence of kid-
ney tubular fragments contaminating our glomerulus
preparation, identification of human-specific genes such
as HLA histocompatibility antigens, or the presence of
blood-derived proteins in our glomerular preparation,
which are difficult to remove from kidney tissueFigure 8 Comparison of human glomerulus proteome with
mouse glomerulus proteome. The human glomerulus proteome
dataset (1,817 proteins, 1,478 genes) was compared with mouse
glomerulus proteome [10]. Gene symbols of the mouse dataset
were converted to corresponding gene symbols of human ortholog
genes by mapping them to an ortholog table of human and mouse
genes based on an “Evola ortholog list” (version 7.5) created by the
Human Invitational Database (H-Inv DB) [17]. Only the gene symbols
of both species that were found in the ortholog table were
compared. See the text for more details.obtained by nephrectomy. On the other hand, identifi-
cation of mouse glomerular proteins was conducted with
laser-microdissected glomerulus from frozen sections of
pre-perfused mouse kidney, allowing the maximal, effect-
ive removal of proteins derived from blood and tubules.
The Human Protein Atlas revealed the uniquely identi-
fied proteins in the glomerulus (343 genes) to be localized
in the kidney (Additional file 11: Table S1). Among them,
162 proteins were found to be localized in the glomerulus
in the Human Protein Atlas immunohistochemistry data-
base. We further inspected the proteins expressed in the
glomerulus to find proteins expressed highly or specifically
in the glomerulus. We found several glomerular proteins
which were also confirmed in the literature to be
glomerulus-specific proteins including cadherin-13
(gene CDH13) [18], RcPTPNS1 or tyrosine-protein
phosphatase non-receptor type substrate 1 (gene
SIRPA) [19], isoform 1 of Crumbs homolog 2 (gene
CRB2) [20,21], and isoform 1 of secretory phospholip-
ase A2 receptor (gene PLA2R1) [22] (Additional file
11: Table S2). It is interesting to note that PLA2R1
was identified as one of the major target antigens in
idiopathic membranous nephropathy [23,24]. Obvi-
ously, further experiments are necessary for confirm-
ation, but it might be possible that these proteins are
specifically or highly enriched in the human glomeru-
lus in comparison to the mouse glomerulus.
Conclusions
The raw data produced by our previous comprehensive
analysis of human glomerulus proteome were reanalyzed
using a high-stringency Mascot search engine to create a
high-confidence, non-redundant dataset of identified
proteins. This approach provided 1,817 unique proteins
representing 1,478 genes and allowed extensive profiling
of glomerulus proteome using bioinformatics tools and
cross-reference analyses with normal human plasma and
urine proteomes, and, in addition, with mouse glomerulus
proteome. The considerable difference in the observed
and calculated pI and Mw of identified proteins was
clearly demonstrated. Analysis based on structured vo-
cabulary of GO indicated the successful identification of
a wide unbiased diversity of proteins, and underscored
significant enrichment of cytoskeletal and extracellular
matrix proteins in the glomerulus proteome. A com-
parison of the dynamic range of our study with two
other proteomic analyses of glomerulus demonstrated
the considerable depth of our proteomic analysis in
terms of dynamic range and coverage. Comparison of
glomerulus proteome with normal human plasma and
urine proteomes revealed protein contamination from
plasma (amounting to 22.1% of proteins identified in
the glomerulus) and excretion into urine (23.4%). A
cross-reference analysis with the Human Protein Atlas
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cifically localized in the glomerulus into urine, suggesting
their possible clinical use as urinary biomarkers for glom-
erular injury. A comparison of ortholog proteins identified
in human and mouse glomeruli showed considerable




The workflow for the preparation of human kidney
glomeruli, the strategy for comprehensive analysis, and
the LC-MS/MS analysis are provided in Additional file 1.
Briefly, 2 mg of proteins extracted from purified glom-
eruli were either separated on 1-D SDS-PAGE (1-D
pre-fractionation) or by 2-D pre-fractionation (solution
phase IEF followed by 1-D SDS-PAGE). All the lanes of
SDS-PAGE gels were cut into 15 slices (90 slices or
fractions in total), and subjected to in-gel digestion to
produce tryptic peptides. Two replicate LC-MS/MS runs
with samples followed by two consecutive LC-MS/MS
runs with blanks (0.3% formic acid) were conducted for
each sample. The latter two blank runs were included to
retrieve and eliminate carryover peptides from the preced-
ing sample runs.
Protein identification using Spectrum Mill
We have previously reported identified proteins using
Spectrum Mill (version A.03.12.060) as a search engine
against the IPI_human protein sequence database (version
3.18) [4]. In this study, we reanalyzed the same raw data
set using a new version of Spectrum Mill (version
03.03.081 SR1a) against the IPI_human protein sequence
database (version 3.70) for convenience of comparison
with proteins identified using the Mascot search engine
against the same version of the IPI-human protein
sequence database. The identification strategy and criteria
for protein identification were similar to those of the
previous report [4]. The protein identification done using
Spectrum Mill is summarized in Table 1.
Protein identification using Mascot
For protein identification with the Mascot search engine,
the raw data files generated by Spectrum Mill were
converted to Mascot generic files (mgf files) by using the
built-in script of Data Analysis software (Agilent version
6.1) without grouping. The 4 mgf files corresponding to
each of the fractions (2 sample runs and 2 blank runs)
were merged, and searched against the IPI_human protein
sequence database (version 3.70) using the Mascot search
engine (version 2.2.1). Cystein carbamoidmethylation was
set as the fixed modification, and other modifications
were set as variable modifications including oxidation
of methionine, oxidation of histidine and tryptophan,N-terminal glutamine to pyroglutamate, and N-terminal
glutamate to pyroglutamate. Peptide and fragment mass
tolerance were set at ±2.5 Da, and at ± 0.7 Da, respect-
ively. A maximum of one missed cleavage was allowed.
Proteins matched with at least one unique peptide and
with peptides of scores above the “identity threshold” were
selected to generate a non-redundant, high-confidence
dataset of identified proteins. Selection of matched pep-
tides with scores exceeding the identity threshold was
performed by using the same value as the significant
threshold in the “Ion score or cut-off” parameter setting.
The significant threshold was adjusted to give a false
discovery rate of less than 1% (0.25 ± 0.24%), which was
calculated on the basis of the number of peptide
matches against a decoy database. Protein identification
is summarized in Table 1 in comparison with data obtained
with Spectrum Mill.Additional files
Additional file 1: Workflow of large-scale proteomic analysis of
normal human kidney glomerulus proteome. The workflow for the
large-scale proteomic analysis of normal human kidney glomerulus
(Panel 1.1) and details of LC-tandem mass analysis (Panel 1.2) are
provided.
Additional file 2: High-confidence, non-redundant dataset of
proteins identified in human kidney glomerulus. Proteins were
identified using Mascot version 2.2.01 searching against the IPI_human
protein sequence database (version 3.70), and reported by integrating all
the results of 90 fractions prepared by 1-D and 2-D pre-fractionation of
2 mg of protein extracted from a highly purified preparation of normal
human kidney glomerulus. See Additional file 1 and the Methods section
for details.
Additional file 3: Summary of proteins identified using Spectrum
Mill and Mascot. A graphic view of Table 1 to illustrate the difference in
the number of proteins identified by the two search engines is shown in
Panel 3.1. Venn diagram for comparison of proteins and genes are also
shown in Panel 3.2.
Additional file 4: Lists of proteins identified in each of the 15
fractions prepared by 1-D pre-fractionation of glomerular proteins.
Proteins identified in each of the 15 slices (fractions) of 1-D SDS-PAGE gel
using Mascot are reported in a corresponding worksheet.
Additional file 5: List of proteins identified in 5 fractions prepared
by 2-D pre-fractionation of glomerular proteins. Proteins identified in
each of the 75 fractions prepared by 2-D pre-fractionation are compiled
in a worksheet.
Additional file 6: Characterization of glomerulus proteome using
bioinformatics tools. All the identified proteins in the non-redundant,
high-confidence dataset of glomerulus proteome were analyzed with
PANTHER analytical tool (ver. 7.0). Subcellular distribution as analyzed
using GO Cellular Component vocabulary (Figure 1A), GO Molecular
Function vocabulary (Figure 1B), and GO Biological Process vocabulary
(Figure 2A) are shown. In addition, enrichment analysis with GO
Biological Process vocabulary and Cytoscape (ver. 2.82) with BinGO plug-
in (ver. 2.42) using the results of whole human genes as a background is
depicted in Figure 2B. Protein classification analysis using PANTHER
Protein Class based on PANTHER Molecular Function ontology is shown
in Figure 3. See the text for further details.
Additional file 7: Under-representation analysis of glomerulus
proteome. All the identified proteins of the non-redundant, high-
confidence dataset of glomerulus proteome consisting of 1,817 unique
proteins representing 1,478 unique genes were analyzed for under-
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vocabulary with Cytoscape version 2.82 coupled with BinGO plug-in
(version 2.42) using the results of whole human genes as a background.
Additional file 8: Glomerular proteins matched in a KEGG
“Regulation of Actin Cytoskeleton” pathway. All the identified
proteins of the non-redundant, high-confidence dataset of glomerulus
proteome consisting of 1,817 unique proteins representing 1,478 unique
genes were analyzed by DAVID KEGG analysis. Matched proteins to
components in the “Regulation of Actin Cytoskeleton” are indicated with
asterisk.
Additional file 9: An estimate of protein contamination from blood
into glomerulus proteome by comparison of glomerulus proteome
with plasma proteome. All the identified proteins of the non-redundant,
high-confidence dataset of glomerulus proteome consisting of 1,817
unique proteins representing 1,478 unique genes were compared with the
high-confidence, non-redundant dataset of normal human plasma
proteome [States DJ et al., Nat. Biotech., 2006, 24, 333–338]. Among the 401
overlapping proteins, proteins annotated as “extracellular space” by GO
Cellular Component vocabulary were selected as representing plasma
proteins. The top 30 plasma proteins are listed in order according to the
number of peptide matches.
Additional file 10: Proteins expressed in the glomerulus excreted
into urine. Among proteins commonly identified in both glomerulus
and urine proteome [Adachi et al., Genome Biol, 2006, 7, R80], the
proteins that were confirmed to be expressed in the glomerulus by
immunohistochemistry (Human Protein Atlas) were selected and
summarized in this file.
Additional file 11: The proteins that might be specifically or
abundantly expressed in human glomerulus compared with mouse
glomerulus. The human glomerular dataset was compared with the
mouse glomerular dataset [Waanders et al., Proc. Natl. Acad. Sci. USA,
2009, 106, 18902–18907]. Gene symbols of the mouse dataset were
converted to corresponding gene symbols of human ortholog genes by
mapping them to an ortholog table of human and mouse genes based
on an “Evola ortholog list” (version 7.5) created by the Human Invitational
database (H-Inv DB). Proteins-corresponding genes uniquely identified in
the human dataset were examined for their cellular localization by
searching in the Human Protein Atlas (version 9.0).
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